Novatek International is pleased to announce that Moscow-based Akrikhin has chosen Nova-Stability for automating and managing their stability process. Nova-Stability offers powerful functionality and is backed by hundreds of user requirements incorporating the in-depth knowledge of numerous experts in the best quality practices driving higher adoption and greater operational efficiency to our clients.
Novatek International is pleased to welcome Akrikhin to our family of Nova-Stability clientele such as 3M, CTI BioPharma, Dial Corporation, Dr. Reddy’s, Emergent BioSolutions, Estee Lauder, Sanofi Genzyme, Green Cross Biotherapeutics Inc., Basic Research, Lifecore BioMedical, Valeant Pharmaceuticals and many more.
Our services are second to none and our implementation and validation timelines easily beat the industry expectations every time! We invite you to evaluate our applications for yourself and find out why Novatek’s Suite of Quality Management software has become the industry standard.
Come see us to learn more at booth number 504 at this year’s 2018 PDA Annual Meeting in Orlando, FL this March!
Akrikhin is one of the leading Russian pharmaceutical companies manufacturing high-quality medicines. We are a part of fast developing international Polpharma Group with strong position in the region of Central and Eastern Europe, Caucasus and Central Asia.